Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Accounts Payables: 2020-2024

Historic Accounts Payables for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $63.3 million.

  • Cellebrite DI's Accounts Payables rose 580.38% to $62.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.5 million, marking a year-over-year increase of 580.38%. This contributed to the annual value of $63.3 million for FY2024, which is 41.22% up from last year.
  • As of FY2024, Cellebrite DI's Accounts Payables stood at $63.3 million, which was up 41.22% from $44.8 million recorded in FY2023.
  • Cellebrite DI's 5-year Accounts Payables high stood at $63.3 million for FY2024, and its period low was $44.8 million during FY2023.
  • In the last 3 years, Cellebrite DI's Accounts Payables had a median value of $45.5 million in 2022 and averaged $51.2 million.
  • In the last 5 years, Cellebrite DI's Accounts Payables fell by 15.90% in 2022 and then surged by 41.22% in 2024.
  • Yearly analysis of 5 years shows Cellebrite DI's Accounts Payables stood at $49.1 million in 2020, then climbed by 10.04% to $54.0 million in 2021, then declined by 15.90% to $45.5 million in 2022, then dropped by 1.34% to $44.8 million in 2023, then skyrocketed by 41.22% to $63.3 million in 2024.